World AMR Congress - Events

Join us at the World Antimicrobial Resistance Congress

November 8-9, 2021    |    Washington, DC    |    Booth 30

Antimicrobial resistance (AMR) is one of the biggest global health crises facing the world today. The number of deaths attributed to AMR is expected to surpass the number of deaths from cancer worldwide by 2050.

Register now on the conference website to attend.

Don't miss:
The Antimicrobial Butterfly Effect and Stewardship Centers of Excellence
Where:

Select the Register tab above to RSVP and upcoming details about this session.

When:

November 8, 2021
14:35 ET


Dr. Robin Patel of Mayo Clinic joins Drs. Maryrose Laguio-Vila and Mary Staicu of Rochester General Hospital to share The Antimicrobial Butterfly Effect and Stewardship Centers of Excellence.
Moderated by Dr. Joseph Campos of Children's National Hospital

Presented by: Robin Patel, MD
Elizabeth P. and Robert E. Allen Professor of Individualized Medicine
Professor of Medicine and Microbiology
Mayo Clinic

Presented by: Maryrose Laguio-Vila, MD
Infectious Disease, Internal Medicine
Rochester Regional Health

Presented by: Mary Staicu, PharmD
Infectious Diseases Clinical Pharmacy Specialist
Rochester General Hospital

Presented by: Joseph Campos, PhD
Director, Microbiology Laboratory and
Infectious Disease Molecular Diagnostics Laboratory
Children's National Hospital

Dr. Robin Patel of Mayo Clinic joins Drs. Maryrose Laguio-Vila and Mary Staicu of Rochester General Hospital to share The Antimicrobial Butterfly Effect and Stewardship Centers of Excellence.
Moderated by Dr. Joseph Campos of Children’s National Hospital

Sign up today to attend this World AMR Congress exclusive session.

Recent Publications

Jul 13, 2021

Impact of the Accelerate PhenoTest® BC Kit on time to results for pathogens from bloodstream infections: IOAS (Improving Outcomes and Antibiotic Stewardship) study experience of 4 hospitals
ECCMID 2021

Jul 13, 2021

Evaluating the impact of the Accelerate PhenoTest® BC Kit on patients with bloodstream infections receiving ineffective empirical antibiotic treatment: IOAS study experience of 4 hospitals
ECCMID 2021

Jul 13, 2021

Antimicrobial use in patients with bloodstream infections from 4 hospitals in the Improving Outcomes and Antibiotic Stewardship (IOAS) study: a quasi-experimental multi-centre study of the Accelerate PhenoTest® BC Kit
ECCMID 2021

See all publications

Learn about our

Technology

What it’s like

Inside Accelerate